Fig. 2. Hypoxic ventilatory responses (AHRs) in 10 subjects measured during three different sessions. Session 1: run 1 = control AHR; run 2 = AHR during 0.1 minimum alveolar concentration (MAC) isoflurane inhalation; run 3: AHR during 0.1 MAC isoflurane inhalation but after pretreatment with antioxidants. Antioxidant pretreatment reverses the inhibiting effect of isoflurane on the hypoxic response in all subjects. Session 2: run 1 = control AHR; run 2 = AHR during 0.1. MAC isoflurane; run 3: AHR + isoflurane but after pretreatment with placebo. Placebo does not alter the inhibiting effect of isoflurane on the AHR. Session 3: run 1 = control AHR; run 2 = AHR during sham isoflurane; run 3: AHR during sham isoflurane but after pretreatment with antioxidant. There is no influence of sham isoflurane and antioxidant on the AHR. 

Fig. 2. Hypoxic ventilatory responses (AHRs) in 10 subjects measured during three different sessions. Session 1: run 1 = control AHR; run 2 = AHR during 0.1 minimum alveolar concentration (MAC) isoflurane inhalation; run 3: AHR during 0.1 MAC isoflurane inhalation but after pretreatment with antioxidants. Antioxidant pretreatment reverses the inhibiting effect of isoflurane on the hypoxic response in all subjects. Session 2: run 1 = control AHR; run 2 = AHR during 0.1. MAC isoflurane; run 3: AHR + isoflurane but after pretreatment with placebo. Placebo does not alter the inhibiting effect of isoflurane on the AHR. Session 3: run 1 = control AHR; run 2 = AHR during sham isoflurane; run 3: AHR during sham isoflurane but after pretreatment with antioxidant. There is no influence of sham isoflurane and antioxidant on the AHR. 

Close Modal

or Create an Account

Close Modal
Close Modal